Medical Oncology

Endocrine Tumors

Questions discussed in this category

What factors aside from progression do you consider most important in determining whether a patient with metastatic papillary thyroid carcinoma is radioactive iodine refractory?

What is your evaluation approach for RAI response? What cumulative dose do you use in practice for deciding a patient is RAI refractory?

3 Answers available

What is the role of liver transplant in NET?

3 Answers available

Would you offer immunotherapy first line for patients with adrenocortical carcinoma outside of a clinical trial?

The phase 2 trial of pembrolizumab in JCO 2019 showed efficacy, and I have patients preferring to avoid chemotherapy.

1 Answer available

Papers discussed in this category

J Endocr Soc, 2019 Oct 11

Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer.

J Clin Oncol, 2020 Jan 1

PD-1 Blockade in Advanced Adrenocortical Carcinoma.

Am J Transplant, 2016 Jun 09

The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors.

Transplantation, 2021 Apr 27

Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors.

Surgery, 2017 Jun 16

Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.

Related Topics in Medical Oncology